Revalia Bio

New Haven, United States

Revalia Bio develops curative drugs for chronic organ-centered disease.

$12.3M raised

Oct 2024

Seed

Top Investors

Sierra VenturesNational Kidney Foundation

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Revalia Bio raised?

Revalia Bio has raised $12.3M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Who are Revalia Bio's investors?

Revalia Bio's investors include Sierra Ventures, National Kidney Foundation.

Where is Revalia Bio headquartered?

Revalia Bio is headquartered in New Haven, United States.

What does Revalia Bio do?

Revalia Bio develops curative drugs for chronic organ-centered disease.

What stage is Revalia Bio at?

Revalia Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 29, 2024.

MLA

"Revalia Bio — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/revalia-bio. Accessed June 3, 2026.

APA

VCBacked. (2024). Revalia Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/revalia-bio

Wikipedia (cite web)

{{cite web |title=Revalia Bio — Funding & Investors |url=https://www.vcbacked.co/company/revalia-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 29, 2024.